Long-term results from the CHAMPION trial: Effect of continued access to pulmonary artery pressure information on the change in rates of admission to hospital for heart failure during open access in the former treatment group (A) and on the change in rates of admission to hospital for heart failure during open access and in the former control group (B). Reprinted from The Lancet, Volume 387, Issue 10017, Abraham et al., Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomized trial, pages 453–461, Copyright 2016, with permission from Elsevier [5].